(Q45867755)

17 December 2017

title

Effective repeat administration with adenovirus vectors to the muscle (English)

1 reference

17 December 2017

1 reference

2

1 reference

17 December 2017

author name string

Chen P

series ordinal

1

1 reference

17 December 2017

Bruder JT

series ordinal

3

1 reference

17 December 2017

publication date

1 April 2000

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

issue

7

1 reference

17 December 2017

page(s)

587-595

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301137

exact match

0 references

cites work

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Characterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Role of adenovirus antigens in the induction of virus neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Humoral response after administration of E1-deleted adenoviruses: immune privilege of the subretinal space

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Fas-ligand: privilege and peril

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Quantitative analysis of repeat adenovirus-mediated gene transfer into injured canine femoral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Gene transfer of Fas ligand induces tumor regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

FasL induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after Systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

7 January 2021

Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

7 January 2021

Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

7 January 2021

Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

7 January 2021

Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

7 January 2021

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

7 January 2021

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

7 January 2021

Intratracheal Gene Delivery with Adenoviral Vector Induces Elevated Systemic IgG and Mucosal IgA Antibodies to Adenovirus andβ-Galactosidase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

7 January 2021

Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

7 January 2021

Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

7 January 2021

Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301137

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301137

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017